SCHEMBL20409783

SCHEMBL20409783

CCOC(C)c1ccc(OCCN2CCOCC2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.62
▸ MAPK1 P28482 2/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CHRM2 P08172 1/20 0.58
▸ CHRM1 P11229 1/20 0.58
▸ HTR2A P28223 1/20 0.58
▸ SCN1A P35498 1/20 0.58
▸ HTR2B P41595 1/20 0.58
▸ KCNH2 Q12809 1/20 0.58
▸ SCN2A Q99250 1/20 0.58
▸ SIGMAR1 Q99720 1/20 0.58
▸ SCN3A Q9NY46 1/20 0.58
▸ HRH3 Q9Y5N1 1/20 0.58
▸ USP2 O75604 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ GAA P10253 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ NPC1 O15118 2/20 0.54
▸ RAB9A P51151 2/20 0.54
▸ MEN1 O00255 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL104326 0.85 MEN1 (0.70) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL23742316 0.84 ALDH1A1 (0.85) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL23742277 0.82 ALDH1A1 (0.66) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL29508217 0.80 ALDH1A1 (0.88) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL15630158 0.79 MEN1 (0.64) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL12204134 0.79 PSMB1 (0.64) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL863648 0.78 ALDH1A1 (0.60) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL10223326 0.78 MEN1 (0.77) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL4485540 0.77 LTA4H (0.69) ALDH1A1MAPK1CYP1A2CHRM2CHRM1
SCHEMBL82383 0.77 ALDH1A1 (0.67) ALDH1A1MAPK1CYP1A2CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018136202-A2 COMPOUNDS AND METHODS FOR CDK8 MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2018-07-26 — — WO disclosed
Send feedback